stockportfolio.pro
The Chemours Company P/E Ratio 2013–2025
The Chemours Company (CC) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -18.4%/yr over 12 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | 35.08 | — |
| FY 2023 | — | — |
| FY 2022 | 7.41 | -7.3% |
| FY 2021 | 7.99 | -48.7% |
| FY 2020 | 15.59 | — |
| FY 2019 | — | — |
| FY 2018 | 3.84 | -58.7% |
| FY 2017 | 9.31 | -97.7% |
| FY 2016 | 400.35 | — |
| FY 2015 | — | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
Source: The Chemours Company SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for The Chemours Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThe Chemours Company — frequently asked questions
What is The Chemours Company's price-to-earnings ratio?
The Chemours Company (CC) reported price-to-earnings ratio of 35.08 for fiscal year 2024, per its SEC filings.
How has The Chemours Company's price-to-earnings ratio changed over time?
Between fiscal 2013 and 2025, CC's price-to-earnings ratio declined at roughly 18.4% per year (compound annual rate), from 400.35 to 35.08.
Where does this data come from?
Figures are computed from The Chemours Company's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.